Penelope G. Papayanni

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Evaluating mesothelin as an immunotherapeutic target for endogenous T cells.

Evaluating mesothelin as an immunotherapeutic target for endogenous T cells.

Journal: Frontiers in immunology

Published: April 11, 2026

Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Journal: Nature medicine

Published: May 16, 2025

Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised.

Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised.

Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Published: February 20, 2024

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay.

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay.

Journal: Frontiers in immunology

Published: September 22, 2023

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy.

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy.

Journal: British journal of haematology

Published: March 28, 2023

Study protocol: Phase I/II trial of induced HLA-G+ regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor.

Study protocol: Phase I/II trial of induced HLA-G+ regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor.

Journal: Frontiers in medicine

Published: February 15, 2023

Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection.

Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection.

Journal: Current issues in molecular biology

Published: May 19, 2022

Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.

Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.

Journal: Immunobiology

Published: April 19, 2022

Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks.

Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks.

Journal: Journal of cellular and molecular medicine

Published: September 29, 2021

Genetic justification of severe COVID-19 using a rigorous algorithm.

Genetic justification of severe COVID-19 using a rigorous algorithm.

Journal: Clinical immunology (Orlando, Fla.)

Published: March 19, 2021

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD).

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD).

Journal: Journal of clinical medicine

Published: March 08, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026